1971•PubMedOpen access

Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome.

Kam S. Tse, Carl E. Arbesman, T. B. Tomasi, D.R. Tourville

Open full text 48 citations

Abstract

IgG, IgA and IgM antibodies reacting with myelin sheaths were found in the sera but not in the cerebrospinal fluid of four out of six patients with Guillain-Barré syndrome. These antibodies had organ specificity for myelin of the central and peripheral nervous systems but did not demonstrate species specificity. Similar antibodies, but in much lower titres, were found infrequently in the sera of patients with liver disease and rarely in normal individuals. The organ specificity and the close correlation between antibody titres and disease activity suggest the possibility that these antibodies may play a role in the pathogenesis of Guillain-Barré syndrome. The detection of antimyelin antibodies by immunofluorescence may provide a relatively simple ancillary laboratory aid in the diagnosis of the neurological entity.

About this research paper

What this paper is about

IgG, IgA and IgM antibodies reacting with myelin sheaths were found in the sera but not in the cerebrospinal fluid of four out of six patients with Guillain-Barré syndrome. These antibodies had organ specificity for myelin of the central and peripheral nervous systems but did not demonstrate species specificity. Similar antibodies, but in much lower titres, were found infrequently in the sera of patients with liver disease and rarely in normal individuals. The organ specificity and the close correlation between antibody titres and disease activity suggest the possibility that these antibodies may play a role in the pathogenesis of Guillain-Barré syndrome. The detection of antimyelin antibodies by immunofluorescence may provide a relatively simple ancillary laboratory aid in the diagnosis of the neurological entity.

Why it matters

OpenAlex reports 48 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

IgG, IgA and IgM antibodies reacting with myelin sheaths were found in the sera but not in the cerebrospinal fluid of four out of six patients with Guillain-Barré syndrome. These antibodies had organ specificity for myelin of the central and peripheral nervous systems but did not demonstrate species specificity. Similar antibodies, but in much lower titres, were found infrequently in the sera of patients with liver disease and rarely in normal individuals. The organ specificity and the close correlation between antibody titres and disease activity suggest the possibility that these antibodies may play a role in the pathogenesis of Guillain-Barré syndrome. The detection of antimyelin antibodies by immunofluorescence may provide a relatively simple ancillary laboratory aid in the diagnosis of the neurological entity.

Key concepts: Guillain-Barre syndrome, Antibody, Immunology, Immunofluorescence, Pathogenesis, Cerebrospinal fluid, Medicine, Myelin

Related papers

Back to paper searchBrowse research topicsOriginal source
Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome. — Research Paper | ScholarLens